Lipoprotein associated phospholipase A2: role in atherosclerosis and utility as a biomarker for cardiovascular risk
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Lipoprotein associated phospholipase A2: role in atherosclerosis and utility as a biomarker for cardiovascular risk
Authors
Keywords
-
Journal
EPMA Journal
Volume 2, Issue 1, Pages 27-38
Publisher
Springer Nature
Online
2011-03-10
DOI
10.1007/s13167-011-0063-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dietary, lifestyle, and clinical predictors of lipoprotein-associated phospholipase A2 activity in individuals without coronary artery disease
- (2010) Ida J Hatoum et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Darapladib and atherosclerotic plaque: Should lipoprotein-associated phospholipase A2 be a therapeutic target?
- (2009) Peter A. McCullough Current Atherosclerosis Reports
- Novel and Conventional Biomarkers for Prediction of Incident Cardiovascular Events in the Community
- (2009) Olle Melander JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effects of lifestyle counseling and combination lipid-modifying therapy on lipoprotein-associated phospholipase A2 mass concentration
- (2009) Kota J. Reddy et al. Journal of Clinical Lipidology
- Relationship of lipoprotein-associated phospholipase A2and oxidized low density lipoprotein in carotid atherosclerosis
- (2009) Kasey C. Vickers et al. JOURNAL OF LIPID RESEARCH
- Fenofibrate reduces lipoprotein associated phospholipase A 2 mass and oxidative lipids in hypertriglyceridemic subjects with the metabolic syndrome
- (2008) Robert S. Rosenson AMERICAN HEART JOURNAL
- Consensus Panel Recommendation for Incorporating Lipoprotein-Associated Phospholipase A2 Testing into Cardiovascular Disease Risk Assessment Guidelines
- (2008) Michael H. Davidson et al. AMERICAN JOURNAL OF CARDIOLOGY
- Review of the Evidence for the Clinical Utility of Lipoprotein-Associated Phospholipase A2 as a Cardiovascular Risk Marker
- (2008) Marshall A. Corson et al. AMERICAN JOURNAL OF CARDIOLOGY
- Effects of the Direct Lipoprotein-Associated Phospholipase A 2 Inhibitor Darapladib on Human Coronary Atherosclerotic Plaque
- (2008) Patrick W. Serruys et al. CIRCULATION
- Lipoprotein-Associated Phospholipase A 2 , Hormone Use, and the Risk of Ischemic Stroke in Postmenopausal Women
- (2008) Sylvia Wassertheil-Smoller et al. HYPERTENSION
- The Effect of Darapladib on Plasma Lipoprotein-Associated Phospholipase A2 Activity and Cardiovascular Biomarkers in Patients With Stable Coronary Heart Disease or Coronary Heart Disease Risk Equivalent
- (2008) Emile R. Mohler et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development
- (2008) Robert L Wilensky et al. NATURE MEDICINE
- Enhanced Expression of Lp-PLA 2 and Lysophosphatidylcholine in Symptomatic Carotid Atherosclerotic Plaques
- (2008) Dallit Mannheim et al. STROKE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search